Eli Lilly and Company (NYSE: LLY), a US-based pharmaceutical company, on Monday announced a dividend for the fourth quarter of 2022.
The company has declared a dividend of USD0.98 per share on outstanding common stock.
The dividend will be paid to shareholders of record as of 15 November 2022, on 9 December 2022.
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
Perrigo announces quarterly dividend
Eli Lilly announces Q4 2023 dividend
Moderna and CEPI partner to accelerate mRNA vaccine development
OptiBiotix secures license agreement with Tata Chemicals for Indian market